References
- Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019 Apr 27;393(10182):1745–1759.
- GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1603–1658.
- Cisternas MG, Murphy L, Sacks JJ, et al. Alternative Methods for Defining Osteoarthritis and the Impact on Estimating Prevalence in a US Population-Based Survey. Arthritis Care Res (Hoboken). 2016 May;68(5):574–580. .
- Safiri S, Kolahi AA, Smith E, et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2020 Jun;79(6):819–828.
- Hootman JM, Helmick CG, Barbour KE, et al. Updated Projected Prevalence of Self-Reported Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation Among US Adults, 2015-2040. Arthritis Rheumatol (Hoboken). 2016 Jul;68(7):1582–1587. .
- Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010 Aug;26(3):355–369.
- Neogi T, Zhang Y. Epidemiology of osteoarthritis. Rheum Dis Clin North Am. 2013 Feb;39(1):1–19.
- Nelson AE. Osteoarthritis year in review 2017: clinical. Osteoarthritis Cartilage. 2018 Mar;26(3):319–325.
- Kurtz SM, Ong KL, Lau E, et al. Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am Vol. 2014 Apr 16;96(8):624–630.
- Dillon CF, Rasch EK, Gu Q, et al. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J Rheumatol. 2006 Nov;33(11):2271–2279.
- Zhang Y, Xu L, Nevitt MC, et al. Comparison of the prevalence of knee osteoarthritis between the elderly Chinese population in Beijing and whites in the United States: the Beijing Osteoarthritis Study. Arthritis Rheumatism. 2001 Sep;44(9):2065–2071. .
- Pincus T, Castrejon I, Yazici Y, et al. Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease. Clin Exp Rheumatol. 2019;37(120(5)):7–17. Sep-Oct.
- Hochberg MC, Cisternas M, Watkins-Castillo S. Osteoarthritis 2019 [cited 2020 Oct 2]. Available from: https://www.boneandjointburden.org/fourth-edition/iiib10/osteoarthritis
- Agency for Healthcare Research and Quality. HCUP Fast Stats. Healthcare Cost and Utilization Project (HCUP) 2019 [cited 2020 Oct 2]. Available from: https://www.hcup-us.ahrq.gov/faststats/NationalProceduresServlet?year1=2014&characteristic1=0&included1=0&year2=2005&characteristic2=0&included2=0&expansionInfoState=hide&dataTablesState=hide&definitionsState=hide&exportState=hide
- Veronese N, Cereda E, Maggi S, et al. Osteoarthritis and mortality: A prospective cohort study and systematic review with meta-analysis. Semin Arthritis Rheum. 2016 Oct;46(2):160–167. .
- March L, Cross M, Lo C, et al. Osteoarthritis: a serious disease. OARSI org; 2016.
- Rutjes AW, Jüni P, da Costa BR, et al. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med. 2012 Aug 7;157(3):180–191.
- Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012 Apr;64(4):465–474. .
- McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014 Mar;22(3):363–388. .
- Kroon FPB, Kortekaas MC, Boonen A, et al. Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial. Lancet. 2019 Nov 30;394(10213):1993–2001.
- Derry S, Conaghan P, Da Silva JA, et al. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2016 Apr 22;4(4):Cd007400.
- Hawker GA. Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019;37(Suppl 120(5)):3–6. Sep-Oct.
- Laslett LL, Doré DA, Quinn SJ, et al. Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial. Ann Rheum Dis. 2012 Aug;71(8):1322–1328. .
- Cai G, Aitken D, Laslett LL, et al. Effect of Intravenous Zoledronic Acid on Tibiofemoral Cartilage Volume Among Patients With Knee Osteoarthritis With Bone Marrow Lesions: A Randomized Clinical Trial. Jama. 2020 Apr 21;323(15):1456–1466.
- Reginster JY. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind randomised, placebo-controlled trial. Ann Rheum Dis. 2014 Feb;73(2):e8.
- Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020 Feb;72(2):149–162. .
- Rannou F, Pelletier JP, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016 Feb;45(4Suppl):S18–21.
- Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019 Nov;27(11):1578–1589. .
- Bruyère O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019 Dec;49(3):337–350. .
- Arden NK, Perry TA, Bannuru RR, et al. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nat Rev Rheumatol. 2020 Oct 28.
- Deshmukh V, Hu H, Barroga C, et al. A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage. 2018 Jan;26(1):18–27. .
- Lane NE. Inhibition of wingless-related integration site (WNT) signalling may treat osteoarthritis of the knee. Trans Am Clin Climatol Assoc. 2020;131:55–64.
- Deshmukh V, O’Green AL, Bossard C, et al. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment. Osteoarthritis Cartilage 2019;27:1347–1360.
- Stampella A, Monteagudo S, Lories R. Wnt signaling as target for the treatment of osteoarthritis. Best Pract Res Clin Rheumatol. 2017 Oct;31(5):721–729.
- Wang Y, Fan X, Xing L, et al. Wnt signaling: a promising target for osteoarthritis therapy. Cell Commun Signal. 2019 Aug 16;17(1):97.
- Lories RJ, Monteagudo S. Review Article: is Wnt Signaling an Attractive Target for the Treatment of Osteoarthritis? Rheumatol Ther. 2020 Jun 7;7(2):259–270.
- Usami Y, Gunawardena AT, Iwamoto M, et al. Wnt signaling in cartilage development and diseases: lessons from animal studies. Lab Invest. 2016 Feb;96(2):186–196. .
- De Boer J, Wang HJ, Van Blitterswijk C. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng. 2004;10(3–4):393–401. Mar-Apr. .
- Day TF, Guo X, Garrett-Beal L, et al. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell. 2005 May 8;(5):739–750. DOI:10.1016/j.devcel.2005.03.016.
- Yazici Y, McAlindon TE, Fleischmann R, et al. A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study. Osteoarthritis Cartilage. 2017 Oct;25(10):1598–1606. .
- Hayami T, Pickarski M, Zhuo Y, et al. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone. 2006 Feb;38(2):234–243. .
- Yazici Y, McAlindon TE, Gibofsky A, et al. Lorecivivint, a Novel Intra-articular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial. Arthritis Rheumatol (Hoboken). 2020 May 20. DOI:10.1002/art.41315.
- Yazici Y, Mcalindon T, Gibofsky A, et al. THU0458 efficacy and safety from a phase 2B trial of SM04690, a novel intra-articular wnt pathway inhibitor for the treatment of osteoarthritis of the knee. Ann Rheum Dis. 2019;78(Suppl2):519.
- Samumed. Samumed Launches Phase 3 Lorecivivint (SM04690) Clinical Program in Knee Osteoarthritis 2019 [cited 2020 Aug 18]. Available from: https://www.samumed.com/medium/image/samumed-launches-phase-3-lorecivivint-sm04690-clinical-program-in-knee-osteoarthritis_556/view.aspx
- Samumed. Samumed Doses First Subject in Phase 3 STRIDES-X-ray Trial of Lorecivivint for the Treatment of Knee Osteoarthritis 2019 [cited 2020 Aug 18]. Available from: https://www.globenewswire.com/news-release/2019/06/19/1871126/0/en/Samumed-Doses-First-Subject-in-Phase-3-STRIDES-X-ray-Trial-of-Lorecivivint-for-the-Treatment-of-Knee-Osteoarthritis.html
- Samumed. Lorecivivint - Samumed 2020 [cited 2020 Aug 18]. Available from: https://adisinsight.springer.com/drugs/800040429
- Samumed L. Samumed Presents Safety Data Analysis of Lorecivivint for Knee Osteoarthritis at the 2019 ACR Annual Meeting 2019 [cited 2020 Aug 18]. Available from: https://www.biospace.com/article/releases/samumed-presents-safety-data-analysis-of-lorecivivint-for-knee-osteoarthritis-at-the-2019-acr-annual-meeting
- Simsek I, Swearingen C, Kennedy S, et al. An integrated safety analysis of lorecivivint, a novel, intra-articular CLK/DYRK1A inhibitor that modulates the WNT pathway, in subjects with knee osteoarthritis. Osteoarthritis Cartilage. 2020;28:S376–S377.
- Hochberg MC, Guermazi A, Guehring H, et al. Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: the FORWARD Randomized Clinical Trial. Jama. 2019 Oct 8;322(14):1360–1370.
- Yogi Berra’s ~ Yogiisms quotations and quotes. [cited 2020 Aug 18]. Available from: https://www.age-of-the-sage.org/quotations/quotes/yogi_berra_yogiisms.html